Description of Medical ServiceThe IPAC Project assessed the outcomes associated with integrating pharmacists providing medication management services into Aboriginal Community Controlled Health Services (ACCHSs) compared with usual care (pre-intervention).
Description of Medical ConditionThe IPAC trial recruited regular clients of ACCHSs who had a diagnosis of:
- Cardiovascular disease (coronary heart disease, stroke, hypertension, dyslipidaemia and any other cardiovascular disease),
- Type 2 diabetes mellitus,
- Chronic kidney disease, or
- Other chronic conditions and at high risk of developing medication-related problems (e.g. polypharmacy).
Reason for applicationThe Sixth Community Pharmacy Agreement provided funding to support a Pharmacy Trial Program (PTP), which seeks to improve clinical outcomes for patients and/or utilise the full scope of a pharmacist’s role in delivering primary health care services.
The outcomes of all PTP Trials will undergo an independent health technology assessment to determine the effectiveness and cost-effectiveness of the trial intervention and inform decisions about any broader rollout. A decision to fund any future programs would be a matter for Government.
Information on the PTP is available on the Department of Health’s website.
Medical Service TypeTherapeutic technology
Previous Application NumberNot applicable
IPAC Public SummaryIPAC Public Summary (PDF 1307 KB)
IPAC Public Summary (Word 695 KB)
Consultation SurveyConsultation Survey (PDF 573 KB)
Consultation Survey (Word 76 KB)
MSAC welcomes public consultation input as per the IPAC Public Summary above.
Please send feedback on this application to commentsMSAC@health.gov.au (and cc: firstname.lastname@example.org) including the MSAC application number 1678 in the subject heading of your email.
MSAC consultation closed 11 February 2022.
For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process
PICO ConfirmationNot applicable
Public Summary DocumentPublic Summary Document (PDF 636 KB)
Public Summary Document (Word 170 KB)